Small molecule · Modulator · developed by Bausch
Adapalene / Benzoyl Peroxide / Clindamycin is a topical combination of a lincosamide antibacterial (clindamycin phosphate), a retinoid (adapalene) that binds retinoic acid nuclear receptors, and benzoyl peroxide, an oxidizing agent with bactericidal and keratolytic effects. It is used topically for acne vulgaris.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Apr 24, 2025). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07524946 | Phase 4 | Acne Vulgaris | Recruiting | BHC |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne Vulgaris
Updated Oct 25, 2026. Something wrong or missing? Report it on the BHC page.
See BHC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
BHC catalysts and pipeline →